Radiation-associated secondary brain tumors after conventional radiotherapy and radiosurgery

Expert Review of Neurotherapeutics

Volumn 13, Issue 5, 2013, Pages 557-565

  Ecemis, Gulcin Cengiz ^a   Atmaca, Aysegul ^b   Meydan, Deniz ^b  

^a Nevsehir Dr I Sevki Atasagun State Hospital   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

conventional radiotherapy; pituitary adenomas; radiation oncogenesis; radiosurgery; radiotherapy

Indexed keywords

BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURGERY; FOLLOW UP; GLIOMA; HUMAN; HYPOPHYSIS ADENOMA; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MENINGIOMA; OUTCOME ASSESSMENT; PATHOGENESIS; PREVALENCE; RADIATION ASSOCIATED SECONDARY BRAIN TUMOR; REVIEW; RISK FACTOR; STEREOTACTIC RADIOSURGERY;

BRAIN NEOPLASMS; HUMANS; NEOPLASMS, RADIATION-INDUCED; PREVALENCE; RADIOSURGERY; RADIOTHERAPY; RISK FACTORS;

EID: 84876941517     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.37     Document Type: Review

References (57)

1. Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev. Endocr. Metab. Disord. 10(2), 135-144 (2009)
2. Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA Jr, Oskouian R. Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J. Neurooncol. 69(1-3), 257-272 (2004)
3. Cahan WG, Woodard HQ. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1(1), 3-29 (1948)
4. Niranjan A, Kondziolka D, Lunsford LD. Neoplastic transformation after radiosurgery or radiotherapy: risk and realities. Otolaryngol. Clin. North Am. 42(4), 717-729 (2009)
5. Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin. Endocrinol. (Oxf.) 35(5), 379-397 (1991)
6. Wu-Chen WY, Jacobs DA, Volpe NJ, Dalmau JO, Moster ML. Intracranial malignancies occurring more than 20 years after radiation therapy for pituitary adenoma. J. Neuroophthalmol. 29(4), 289-295 (2009)
7. Berman EL, Eade TN, Brown D et al. Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report. Neurosurgery 61(5), E1099; discussion E1099 (2007)
8. Epstein R, Hanham I, Dale R. Radiotherapy-induced second cancers: are we doing enough to protect young patients? Eur. J. Cancer 33(4), 526-530 (1997)
9. Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery 52(6), 1436-1440; discussion 1440 (2003)
10. Widel M, Przybyszewski W, Rzeszowska-Wolny J. Radiation-induced bystander effect: the important part of ionizing radiation response. Potential clinical implications. Postepy. Hig. Med. Dosw. (Online) 63, 377-388 (2009)
11. Balasubramaniam A, Shannon P, Hodaie M, Laperriere N, Michaels H, Guha A. Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro-oncology 9(4), 447-453 (2007)
12. Chan A, Cardinale R, Loeffler J. Stereotactic irradiation. In: Principles and Practice of Radiation Oncology. Perez CA, Brady LW, Halperin CA, Schmidt-Ullrich RK (Eds). Lippincott Williams & Wilkins, PA, USA, 410 (2004)
13. Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J. Clin. Endocrinol. Metab. 96(7), 1992-2003 (2011)
14. Mayberga M, Vermeulenb S. Advances in stereotactic radiosurgery in the treatment of pituitary adenomas. Curr. Opin. Endocrinol. Diabetes Obes. 14(4), 296-300 (2007)
15. Ron E, Modan B, Boice JD Jr et al. Tumors of the brain and nervous system after radiotherapy in childhood. N. Engl. J. Med. 319(16), 1033-1039 (1988)
16. Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol. Clin. 21(1), 249-277 (2003)
17. Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J. Neurosurg. 97(5), 1078-1082 (2002)
18. Brada M, Ford D, Ashley S et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304(6838), 1343-1346 (1992)
19. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J. Clin. Endocrinol. Metab. 90(2), 800-804 (2005)
20. Breen P, Flickinger JC, Kondziolka D, Martinez AJ. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J. Neurosurg. 89(6), 933-938 (1998)
21. al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J. Neurosurg. 73(4), 502-512 (1990)
22. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 30(3), 557-565 (1994)
23. Fisher BJ, Gaspar LE, Noone B. Radiation therapy of pituitary adenoma: delayed sequelae. Radiology 187(3), 843-846 (1993)
24. Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin. Oncol. (R. Coll. Radiol). 6(6), 361-363 (1994)
25. Erfurth EM, Bülow B, Mikoczy Z, Svahn-Tapper G, Hagmar L. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour? Clin. Endocrinol. (Oxf.) 55(5), 613-616 (2001)
26. Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R. Failure of radiotherapy in acromegaly. Eur. J. Endocrinol. 145(6), 717-726 (2001)
27. Epaminonda P, Porretti S, Cappiello V, Beck-Peccoz P, Faglia G, Arosio M. Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGFBP-3 levels in acromegaly. Clin. Endocrinol. 55(2), 183-189 (2001)
28. Norberg L, Johansson R, Rasmuson T. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours. Clin. Endocrinol. (Oxf.) 68(5), 780-785 (2008)
29. Snead FE, Amdur RJ, Morris CG, Mendenhall WM. Long-term outcomes of radiotherapy for pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys. 71(4), 994-998 (2008)
30. Erridge SC, Conkey DS, Stockton D et al. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother. Oncol. 93(3), 597-601 (2009)
31. Norberg L, Johansson R, Rasmuson T. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden. Acta Oncol. 49(8), 1276-1282 (2010)
32. Sattler MG, van Beek AP, Wolffenbuttel BH et al. The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother. Oncol. 104(1), 125-130 (2012)
33. Diallo I, Haddy N, Adjadj E et al. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int. J. Radiat. Oncol. Biol. Phys. 74(3), 876-883 (2009)
34. Suh JH, Chao ST, Weil RJ. Pituitary tumors. In: Clinical Radiation Oncology. Gunderson LL, Tepper JE (Eds). Elsevier Saunders, PA, USA, 493-509 (2012)
35. Larson DA, Flickinger JC, Loeffler JS. The radiobiology of radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 25(3), 557-561 (1993)
36. Nishioka H, Hirano A, Haraoka, J Nakajima N. Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology 22(1), 19-25 (2002)
37. Yu JS, Yong WH, Wilson D, Black KL. Glioblastoma induction after radiosurgery for meningioma. Lancet 356(9241), 1576-1577 (2000)
38. Shamisa A, Bance M, Nag S et al. Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J. Neurosurg. 94(5), 816-821 (2001)
39. Kaido T, Hoshida T, Uranishi R et al. Radiosurgery-induced brain tumor. Case report. J. Neurosurg. 95(4), 710-713 (2001)
40. McIver JI, Pollock BE. Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: case report and literature review. J. Neurooncol. 66(3), 301-305 (2004)
41. Sheehan J, Yen CP, Steiner L. Gamma knife surgery-induced meningioma. Report of two cases and review of the literature. J. Neurosurg. 105(2), 325-329 (2006)
42. Comey CH, McLaughlin MR, Jho HD, Martinez AJ, Lunsford LD. Death from a malignant cerebellopontine angle triton tumor despite stereotactic radiosurgery. Case report. J. Neurosurg. 89(4), 653-658 (1998)
43. Norén G. Long-term complications following gamma knife radiosurgery of vestibular schwannomas. Stereotact. Funct. Neurosurg. 70(Suppl. 1), 65-73 (1998)
44. Thomsen J, Mirz F, Wetke R, Astrup J, Bojsen-Møller M, Nielsen E. Intracranial sarcoma in a patient with neurofibromatosis type 2 treated with gamma knife radiosurgery for vestibular schwannoma. Am. J. Otol. 21(3), 364-370 (2000)
45. Hanabusa K, Morikawa A, Murata T, Taki W. Acoustic neuroma with malignant transformation. Case report. J. Neurosurg. 95(3), 518-521 (2001)
46. Bari ME, Forster DM, Kemeny AA, Walton L, Hardy D, Anderson Jr. Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature. Br. J. Neurosurg. 16(3), 284-289 (2002)
47. Shin M, Ueki K, Kurita H, Kirino T. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet 360(9329), 309-310 (2002)
48. Kubo O, Chernov M, Izawa M et al. Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim. Invasive Neurosurg. 48(6), 334-339 (2005)
49. Schmitt WR, Carlson ML, Giannini C, Driscoll CL, Link MJ. Radiation-induced sarcoma in a large vestibular schwannoma following stereotactic radiosurgery: case report. Neurosurgery 68(3), E840-E846; discussion E846 (2011)
50. Yang T, Rockhill J, Born DE, Sekhar LN. A case of high-grade undifferentiated sarcoma after surgical resection and stereotactic radiosurgery of a vestibular schwannoma. Skull Base 20(3), 179-183 (2010)
51. Tanbouzi Husseini S, Piccirillo E, Taibah A, Paties CT, Rizzoli R, Sanna M. Malignancy in vestibular schwannoma after stereotactic radiotherapy: a case report and review of the literature. Laryngoscope 121(5), 923-928 (2011)
52. Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60(1), 60-65; discussion 65 (2007)
53. Santacroce A, Walier M, Régis J et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery 70(1), 32-39; discussion 39 (2012)
54. Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications from a 22-year experience. Int. J. Radiat. Oncol. Biol. Phys. 83(5), 1414-1418 (2012)
55. Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 69(2), 284-293 (2011)
56. Muracciole X, Cowen D, Régis J. Radiosurgery and brain radio-induced carcinogenesis: update. Neurochirurgie 50(2-3 Pt 2), 414-420 (2004)
57. Pollock BE. Comparing radiation therapy and radiosurgery for pituitary adenoma patients. World Neurosurg. 78(1-2), 58-59 (2012)